Literature DB >> 30021408

Pregabalin and dexmedetomidine conscious sedation for flexible bronchoscopy: a randomized double-blind controlled study.

Ezzeldin Ibrahim1, Wesameldin Sultan2, Saffa Helal2, Hatem Abo-Elwafa2, Ahmed Abdelaziz2.   

Abstract

BACKGROUND: Conscious sedation is usually required during flexible bronchoscopy. Sedation should be achieved without respiratory depression or loss of consciousness. The present study was designed to evaluate the effect of pregabalin premedication on reducing the amount of sedatives and to show its advantages for patients undergoing flexible bronchoscopy with dexmedetomidine.
METHODS: Seventy patients undergoing elective flexible bronchoscopy were randomly divided into two groups of 35 patients each. All patients received premedication one hour before the procedure. PG group received 150 mg pregabalin and C group received placebo. All patients were sedated with dexmedetomidine infusion to achieve optimum sedation. During the procedure peripheral oxygen saturation, respiratory rate, hemodynamics, Ramsay sedation Score, cough score, and total amount of dexmedetomidine used were recoded. After the procedure patients' and pulmonologists' satisfaction were compared.
RESULTS: The total amount of dexmedetomidine used in PG was less compared to C group (P=0.01). Sedation score was higher in PG group at the time of theatre admission (P<0.001). Cough score was higher, but insignificant in group C (P=0.08). Patients' and pulmonologists' satisfaction scores were higher in group PG (P=0.007 and 0.001 respectively). The heart rate and mean arterial pressure were lower in the C group (P=0.02 and 0.03 respectively). Postoperative care unit stay was less in group PG with less analgesic requirements.
CONCLUSIONS: Conscious sedation facilitates flexible bronchoscopy. Premedication with pregabalin can reduce the amount of sedatives. Dexmedetomidine with pregabalin premedication has many advantages over dexmedetomidine alone.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30021408     DOI: 10.23736/S0375-9393.18.12685-X

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  4 in total

1.  The Efficacy and Safety of Remimazolam Tosilate Versus Dexmedetomidine in Outpatients Undergoing Flexible Bronchoscopy: A Prospective, Randomized, Blind, Non-Inferiority Trial.

Authors:  Xingfang Chen; Deqian Xin; Guangjun Xu; Jing Zhao; Qing Lv
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Protective effect of dexmedetomidine on kidney injury of parturients with preeclampsia undergoing cesarean section: a randomized controlled study.

Authors:  Qing-Lin Zhang; Lei Wang; Ming-Jun Xu; Tian-Long Wang
Journal:  Biosci Rep       Date:  2019-05-03       Impact factor: 3.840

3.  Dexmedetomidine postconditioning provides renal protection in patients undergoing laparoscopic partial nephrectomy: A randomized controlled trial.

Authors:  Lingling Jiang; Tao Zhang; Yang Zhang; Dexin Yu; Ye Zhang
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

4.  Nebulized dexmedetomidine-lidocaine inhalation as a premedication for flexible bronchoscopy: a randomized trial.

Authors:  Wei Gu; Meiying Xu; Huijie Lu; Qi Huang; Jingxiang Wu
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.